Menú

| UNINET | Lista de correo: eusalud-l | Suscripciones | Club AUTOPSIAS | REA::EJAUTOPSY
Casos PAT::UNINET | BIOMED::UNINET | MisApuntes | ASION

CHD5 gen supresor de tumores

CEB (@ceb_edu) twitteó a las 8:41 AM on lun, ene 14, 2013:
Descubierto el gen supresor tumoral mas potente, Chd5. Protege el genoma celular uniendose a H3 http://t.co/xkl3e4qt
(https://twitter.com/ceb_edu/status/290725326680641536)

Created with Drupal Editor

La vacuna del HPV en USA menos usada que en Canada, UK o Australia

Medscape (@Medscape) twitteó a las 7:02 PM on mié, ene 09, 2013:
HPV vaccination coverage in US is lower than in Canada, UK, Australia; years later will cancer rates be higher? http://t.co/2QjmHAAi
(https://twitter.com/Medscape/status/289069636065034241

____
Eusalud

Descenso de la mortalidad del cancer en relación con el éxito de la vacuna contra el HPV

NCI Prevention (@NCIprevention) twitteó a las 4:55 PM on mar, ene 08, 2013:
NCI reports cancer death rates still dropping: looks at role of HPV in cancer rates & value of HPV vaccination. http://t.co/412IhN12
(https://twitter.com/NCIprevention/status/288675225623752705)

____
Eusalud

Avances en la Hepatitis C

NCI News & Media (@NCIMedia) twitteó a las 5:56 PM on mar, ene 08, 2013:
Scientists have discovered a gene that interferes with the clearance of #hepatitis C #virus #infection http://t.co/FUmCCmPR
(https://twitter.com/NCIMedia/status/288690699438784513)

____
Eusalud

Cervical cancer screening en USA

Medscape Oncology (@MedscapeOnc) twitteó a las 0:47 AM on sáb, ene 05, 2013:
#Oncology What's Going On With Cervical Cancer Screening in US? http://t.co/YXaCoDaQ
(https://twitter.com/MedscapeOnc/status/287344495320772609)
Created with Drupal Editor

Enzalutamide y Ca. próstata

Medscape Oncology (@MedscapeOnc) twitteó a las 4:28 AM on sáb, ene 05, 2013:
(Prostate Cancer) Enzalutamide: New Weapon Against Metastatic Prostate Cancer http://t.co/BWVjMuAk
(https://twitter.com/MedscapeOnc/status/287400229857271808)

Created with Drupal Editor

Leeds Virtual Pathology

Virtual Pathology (@LeedsPathology) twitteó a las 0:42 PM on jue, ene 03, 2013:
Happy New Year. 5000 slides in the slide library! http://t.co/yLlClKoQ
(https://twitter.com/LeedsPathology/status/286799818184093696)

Created with Drupal Editor

SaneVax Inc desarrolla un nuevo método de PCR para evaluar la detección de HPV en pacientes postmortem vacunados con Gardasil

OrganizedWisdom HPV (@HPV_Wisdom) twitteó a las 10:59 AM on mar, ene 01, 2013: SaneVax: Newly Developed Same-Nested PCR Method May Help Answer Questions Regarding HPV Vaccine Safety: SaneVax ... http://t.co/1fMHnYjb
(https://twitter.com/HPV_Wisdom/status/286049093107732480)

Lee SH. Detection of human papillomavirus L1 gene DNA fragments in postmortem blood and spleen after Gardasil® vaccination—A case report
Advances in Bioscience and Biotechnology 2012, 3, 1214-1224. doi: 10.4236/abb.2012.38148. DOI: 10.4236/abb.2012.38148

¿Qué es un ensayo clínico?

Red Oncología (@redoncologia) twitteó a las 0:01 PM on lun, dic 31, 2012:
RT @_SEOM: Los #ensayosclinicos son fundamentales para avanzar en #cancer. Conoce lo que son y por qué participar http://t.co/qAPCv6nT
(https://twitter.com/redoncologia/status/285702157351665664)

Created with Drupal Editor

NEJM 1997 genes BRCA y cáncer de mama y ovario

NEJM Team (@NEJMTeam) twitteó a las 2:00 PM on vie, dic 28, 2012:
1997 study showed #breastcancer or #ovariancancer would develop in most women with BRCA1, BRCA2 genes. More: http://t.co/QoujY2oP #NEJM200

Fuente: @NEJMTeam via Twitter

Pathos: Caso 156 Schwannoma gástrico

Anatomía Patológica (@ProyectoPathos) twitteó a las 7:42 PM on dom, dic 02, 2012:
Nuevo caso (156) en el banco de casos: (registro gratuito) http://t.co/cgTxnELO
(https://twitter.com/ProyectoPathos/status/275309042396708864)

(Para descargar el caso es preciso registrarse en el servidor de Pathos)
____
Eusalud

Genotype distribution of HPV in Madrid, Spain

Genotype distribution of human papillomavirus (HPV) in histological sections of cervical intraepithelial neoplasia and invasive cervical carcinoma in Madrid, Spain

Benjamín García-Espinosa, Ernesto Moro-Rodríguez and Emilio Álvarez-Fernández

Abstract: Background. Human Papillomavirus (HPV) genotype distribution and co-infection occurrence was studied in cervical specimens from the city of Madrid (Spain), as a contribution to the knowledge of Human Papillomavirus genotype distribution and prevalence of carcinogenic HPV types in cervical lesions in Spain. Methods: A total of 533 abnormal specimens, from the Hospital General Universitario “Gregorio Marañón” of Madrid, were studied. These included 19 benign lesions, 349 cervical intraepithelial neoplasias 1 (CIN1), 158 CIN2-3 and 7 invasive cervical carcinomas (ICC). HPV genotyping was performed using PCR and tube array hybridization. Results: We detected 20 different HPV types: 13 carcinogenic high-risk HPV types (HR-HPVs), 2 probably carcinogenic high-risk HPV types (PHR-HPVs) and 5 carcinogenic low-risk HPV types (LR-HPVs). The most frequent HPV genotypes found in all specimens were HPV16 (26.0%), 31 (10.7%) and 58 (8.0%). HPV 18 was only detected in 5.0%. Co-infections were found in 30.7% of CIN 1 and 18.4% cases of CIN2-3. The highest percentage of HR HPVs was found in those specimens with a CIN2-3 lesion (93.7%). Conclusion: As our study shows the current tetravalent vaccine could be effective in our geographical area for preventing all the invasive cervical carcinomas. In addition, upon the estimates of the important presence of other HR-HPV types – such as 31, 58, 33 and 52 – in different preneoplasic lesions the effectiveness of HPV vaccination in our geographical area, and others with similar genotype distribution, should be limited.

BMC Cancer 2012, 12:533 doi:10.1186/1471-2407-12-533

Fuente: J. Ernesto Moro (@EMoroRodriguez) twitteó a las 2:53 PM on mié, nov 28, 2012: #bmccancer Genotype distribution of HPV in histological sections in CIN and invasive cervical ca. in Madrid, Spain http://t.co/McFFKvnj